DEPUY IRELAND

Manufacturer adverse-event records for DEPUY IRELAND come from the U.S. Food & Drug Administration (FDA) MAUDE database via openFDA, refreshed March 2026 - see our methodology. Not medical advice.

FDA MAUDE device safety record · 2009–2026 · thin-book · quiet Death-code · injury-heavy

Volume signature

DEPUY IRELAND is a thinner MAUDE footprint

DEPUY IRELAND accounts for 4,634 FDA MAUDE reports (#386 of 434, thin-book tercile). Death-coded event_type share is 0.00% (quiet); Injury share 51.7% (injury-heavy).

What the volume reading shows for DEPUY IRELAND

The standout signal for DEPUY IRELAND is filing volume: 4,634 adverse-event reports in FDA MAUDE (#386 of 434, thin-book). Death-coded event_type share sits at 0.00% (quiet).

As a thinner-book manufacturer, a handful of device families can swing the totals; open the device table rather than reading the company headline alone. Event_type counts are not the same population as Patient Outcomes.

Reports span 20 device types, led in this extract by Injury at 2,394 (51.7% of event_type total). Peak single-year volume reaches 1,356 reports across 16 years. These are raw FDA submissions, not adjudicated findings. Snapshot . Verify current communications on the FDA MDR page.

4,634
Total Reports
0
Event-type Death
2,394
Injury Reports
20
Device Types

Event Types

Injury 2,394 (51.7%)
Malfunction 2,240 (48.3%)

Patient Outcomes

FDA patient-outcome codes (separate from event_type). Percentages use this chart's row total.

Required Intervention 2,344 (51.3%)
2,177 (47.6%)
Other 45 (1.0%)
R 3 (0.1%)
Hospitalization 1 (0.0%)

Yearly Trend

09
2009: 4
10
2010: 6
11
2011: 457
12
2012: 1,356
13
2013: 73
14
2014: 90
15
2015: 30
16
2016: 33
17
2017: 60
19
2019: 1
21
2021: 4
22
2022: 169
23
2023: 282
24
2024: 724
25
2025: 1,036
26
2026: 309